Florida HB 353: Autonomous Vehicles

Bill Text

CS/HB 353 2026

CODING: Words stricken are deletions; words underlined are additions.
hb353-01-c1
Page 1 of 2
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S

A bill to be entitled 1
An act relating to sickle cell disease treatment of 2
pain continuing education; amending s. 456.0301, F.S.; 3
revising requirements for a continuing education 4
course on prescribing controlled substances; providing 5
an effective date. 6
7
Be It Enacted by the Legislature of the State of Florida: 8
9
Section 1. Paragraph (a) of subsection (1) of section 10
456.0301, Florida Statutes, is amended to read: 11
456.0301 Requirement for instruction on controlled 12
substance prescribing.— 13
(1)(a) The appropriate board shall require each person 14
registered with the United States Drug Enforcement 15
Administration and authorized to prescribe controlled substances 16
pursuant to 21 U.S.C. s. 822 to complete a board-approved 2-hour 17
continuing education course on prescribing controlled substances 18
offered by a statewide professional association of physicians in 19
this state that is accredited to provide educational activities 20
designated for the American Medical Association Physician's 21
Recognition Award Category 1 Credit or the American Osteopathic 22
Category 1-A continuing medical education credit as part of 23
biennial license renewal. The course must include information on 24
the current standards for prescribing controlled substances, 25

CS/HB 353 2026

CODING: Words stricken are deletions; words underlined are additions.
hb353-01-c1
Page 2 of 2
F L O R I D A H O U S E O F R E P R E S E N T A T I V E S

particularly opiates; alternatives to these standards; 26
nonpharmacological therapies; prescribing emergency opioid 27
antagonists; and the risks of opioid addiction following all 28
stages of treatment in the management of acute pain; and the 29
treatment of pain for patients with sickle cell disease. The 30
course may be offered in a distance learning format and must be 31
included within the number of continuing education hours 32
required by law. The department may not renew the license of any 33
prescriber registered with the United States Drug Enforcement 34
Administration to prescribe controlled substances who has failed 35
to complete the course. The course must be completed by January 36
31, 2019, and at each subsequent renewal. This paragraph does 37
not apply to a licensee who is required by his or her applicable 38
practice act to complete a minimum of 2 hours of continuing 39
education on the safe and effective prescribing of controlled 40
substances. 41
Section 2. This act shall take effect July 1, 2026. 42